Skip to main content
. 2023 Feb 28;46:101156. doi: 10.1016/j.gore.2023.101156

Fig. 2.

Fig. 2

(A) Independent t test of the Khorana score between patients without venous thromboembolism (No VTE) and patients that were diagnosed with venous thromboembolism (VTE). (B) Independent t test of the Khorana score between the neoadjuvant/definitive chemotherapy (NA/DCT) subgroup and adjuvant chemotherapy (ACT) subgroup.